Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY32.80 CNY
Change Today +0.19 / 0.58%
Volume 12.5M
002437 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

harbin gloria pharmaceutic-a (002437) Snapshot

Open
CNY32.40
Previous Close
CNY32.61
Day High
CNY33.12
Day Low
CNY32.01
52 Week High
03/25/15 - CNY35.38
52 Week Low
03/31/14 - CNY19.72
Market Cap
24.0B
Average Volume 10 Days
22.0M
EPS TTM
CNY0.56
Shares Outstanding
731.9M
EX-Date
07/4/14
P/E TM
58.6x
Dividend
CNY0.04
Dividend Yield
0.12%
Current Stock Chart for HARBIN GLORIA PHARMACEUTIC-A (002437)

Related News

No related news articles were found.

harbin gloria pharmaceutic-a (002437) Related Businessweek News

No Related Businessweek News Found

harbin gloria pharmaceutic-a (002437) Details

Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China. The company offers orthopedic medicines, antineoplastic products, medical-nutrition products, rheumatology drugs, digestive and respiratory system medicines, cardiovascular medicines, liver disease medications, gynecology medications, and antibiotics. It also provides circulatory system, pediatrics, uropoiesis and reproduction, immune regulation, and other products. Harbin Gloria Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Harbin, the People’s Republic of China.

Founded in 2000

harbin gloria pharmaceutic-a (002437) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

harbin gloria pharmaceutic-a (002437) Key Developments

Harbin Gloria Pharmaceuticals Co., Ltd, Special/Extraordinary Shareholders Meeting, Feb 09, 2015

Harbin Gloria Pharmaceuticals Co., Ltd, Special/Extraordinary Shareholders Meeting, Feb 09, 2015., at 14:00 China Standard Time. Agenda: To consider the eligibility for non-public share offering; to consider scheme for non-public share offering; to consider the preplan for non-public share offering; to consider feasibility report on use of proceeds from the non-public share offering; to consider special report on use of previously raised funds; to sign the conditional share subscription contracts with non-public issuance targets; to consider connected transactions involved in the non-public share offering; to consider acquisition of 85.01% equity stake in a company; to consider authorization to the board to handle matters in relation to non-public share offering; to consider a company to sign an exclusive sales agent agreement with two companies; and to consider the election of Wang Ruihua as independent director.

Harbin Gloria Pharmaceuticals Co., Ltd Approves Amendments to Articles of Association

Harbin Gloria Pharmaceuticals Co. Ltd. held its first extraordinary general meeting of 2015 on January 12, 2015. At the meeting the company approved the amendments to the articles of association of the company.

Harbin Gloria Pharmaceuticals Co., Ltd, Special/Extraordinary Shareholders Meeting, Jan 12, 2015

Harbin Gloria Pharmaceuticals Co., Ltd, Special/Extraordinary Shareholders Meeting, Jan 12, 2015., at 14:00 China Standard Time. Agenda: To consider amendments to the articles of association of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002437:CH CNY32.80 CNY +0.19

002437 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002437.
View Industry Companies
 

Industry Analysis

002437

Industry Average

Valuation 002437 Industry Range
Price/Earnings 52.0x
Price/Sales 12.7x
Price/Book 8.4x
Price/Cash Flow 54.0x
TEV/Sales 12.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HARBIN GLORIA PHARMACEUTIC-A, please visit www.gloria.cc. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.